Patent Assignment
Reel/Frame 026716/0136
Assignment of Assignor's Interest
Recorded: 2011-08-08
Pages: 11
Assignors
CAVENEE, WEBSTER
Executed: 2011-05-10
FURNARI, FRANK
Executed: 2011-05-10
JOHNS, TERRANCE GRANT
Executed: 2011-05-25
SCOTT, ANDREW M.
Executed: 2011-05-10
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
666 THIRD AVENUE, NEW YORK, NEW YORK, 10017
Covered Properties
(2)
Treatment Method Using Egfr Antibodies and Src Inhibitors and Related Formulations
Treatment method using EGFR antibodies and src inhibitors and related formulations
Application:
60/918,084 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Aug 3, 2009
From: LUDWIG INSTITUTE FOR CANCER RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023043/0402 →
Assignment of Assignor's Interest
Nov 3, 2011
From: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 027168/0281 →
Confirmatory License
Nov 14, 2011
From: LUDWIG INSTITUTE FOR CANCER RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027226/0522 →